Yesterday I posted a comment on a recent decision from the Alabama Supreme Court on the possible liability of a brand-name drug manufacturer for injuries related to defective warnings provided by a generics drug manufacturer. Looking for some information on the topic I found the video that appears below of a panel at a conference on the subject. I just found it a few minutes ago and I have not had a chance to watch it, so I can't comment on it. (One note: when the panelists (or the literature) uses the term "innovator" they are referring to the "name-brand manufacturer.") Here is the video:
No comments:
Post a Comment